Anti-D human immunoglobulin (Mitsubishi Tanabe)

N/A

Report date: 2022/02/11 17:35:08

Base Information

Drug NameAnti-D human immunoglobulin (Mitsubishi Tanabe)

Drug Alias Name抗D免疫qi (Mitsubishi Tanabe)Anti-D Rho immunoglobulin (Mitsubishi Tanabe)Anti-D Human Immunoglobulin (Mitsubishi Tanabe)抗RhoD免疫qiu (Mitsubishi Tanabe)Dry anti-Rho(D) immune human globulin (Mitsubishi Tanabe) +[6]

ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components

Mechanisms of ActionBlood group Rh(D) polypeptide inhibitors

TargetsBlood group Rh(D) polypeptide

Therapy Area/IndicationsErythroblastosis, Fetal

Global Approved IndicationsErythroblastosis, Fetal

Approved Indications in ChinaN/A

Original Approved Country/TerritoryJapan

Original Approved Date2000/03/08

Country/TerritoryJapan

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesMitsubishi Tanabe Pharma Corp

China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma

Inactive CompaniesN/A

Active IndicationsErythroblastosis, Fetal

Inactive IndicationsN/A

Other Information

ATC CodeJ06BB01